3-iodobenzylguanidine has been researched along with ephedrine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, IR; Haka, MS; Kuhl, DE; Rosenspire, KC; Schwaiger, M; Shapiro, B; Shulkin, BL; Sisson, JC; Thompson, NW; Wieland, DM | 1 |
| Allman, K; Calkins, H; Lehmann, MH; Schwaiger, M; Wieland, D | 1 |
| Baro, ME; Castle, VP; Dole, MG; Hutchinson, RJ; Mitchell, DS; Rawwas, JB; Shulkin, BL; Sisson, JC; Ungar, DR; Wieland, DM | 1 |
| Stevens, MJ | 1 |
| L'Abbate, A; Sambuceti, G | 1 |
| Byrd, DR; Kinahan, PE; Krohn, KA; Link, JM; Mankoff, DA; Mann, GN; Pham, P; Pickett, CA | 1 |
| Chen, WP; Kajinami, K; Matsunari, I; Matsuya, T; Murakami, Y; Nakajima, K; Nekolla, SG; Nomura, Y; Takamatsu, H; Taki, J | 1 |
| Franzius, C; Hermann, K; Juergens, KU; Kopka, K; Schober, O; Vormoor, J; Weckesser, M | 1 |
| Aoki, H; Chen, WP; Kajinami, K; Kinuya, S; Matsunari, I; Nakajima, K; Nekolla, SG; Nomura, Y; Takeda, N; Taki, J | 1 |
| Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
| Abraham, R; Bengel, FM; Dannals, RF; Fukushima, K; Higuchi, T; Isoda, T; Javadi, MS; Rischpler, C; Wahl, R | 1 |
| Ito, YM; Kasai, K; Katoh, C; Kuge, Y; Magota, K; Manabe, O; Nishijima, K; Suzuki, E; Tamaki, N; Tomiyama, Y; Yoshinaga, K | 1 |
| Amanullah, A; Gupta, S | 1 |
| Dilsizian, V; Eckelman, WC | 1 |
| Higuchi, T; Javadi, M; Lapa, C; Nekolla, SG; Onthank, D; Rischpler, C; Robinson, S; Samnick, S; Schwaiger, M; Werner, RA | 1 |
| Carnagarin, R; Chan, JJS; Dwivedi, G; Ho, JK; Kiuchi, MG; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Schlaich, MP; Villacorta, H | 1 |
| Ahmadi, A; Beanlands, RS; deKemp, RA; Mielniczuk, LM; Nair, GM; Narula, J; Rotstein, BH; Zelt, JGE | 1 |
5 review(s) available for 3-iodobenzylguanidine and ephedrine
| Article | Year |
|---|---|
New imaging techniques for cardiovascular autonomic neuropathy: a window on the heart.
Topics: 3-Iodobenzylguanidine; Animals; Carbon Radioisotopes; Cardiovascular Diseases; Diabetic Neuropathies; Ephedrine; Heart; Heart Conduction System; Humans; Models, Biological; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
PET/CT imaging in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed | 2013 |
Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Cardiac Resynchronization Therapy; Cardiomyopathies; Cardiotoxicity; Death, Sudden, Cardiac; Ephedrine; Heart; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Prognosis; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2015 |
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Catecholamines; Death, Sudden, Cardiac; Disease Models, Animal; Ephedrine; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure.
Topics: 3-Iodobenzylguanidine; Ephedrine; Heart; Heart Failure; Humans; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2020 |
1 trial(s) available for 3-iodobenzylguanidine and ephedrine
| Article | Year |
|---|---|
[11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Ephedrine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
11 other study(ies) available for 3-iodobenzylguanidine and ephedrine
| Article | Year |
|---|---|
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Carbon Radioisotopes; Ephedrine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Pheochromocytoma; Tomography, Emission-Computed | 1992 |
Scintigraphic pattern of regional cardiac sympathetic innervation in patients with familial long QT syndrome using positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adult; Carbon Radioisotopes; Ephedrine; Female; Heart Conduction System; Humans; Iodine Radioisotopes; Iodobenzenes; Long QT Syndrome; Male; Middle Aged; Sympathetic Nervous System; Tomography, Emission-Computed | 1993 |
PET hydroxyephedrine imaging of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adult; Carbon Radioisotopes; Child; Child, Preschool; Contrast Media; Deoxyglucose; Ephedrine; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Time Factors; Tomography, Emission-Computed | 1996 |
Studying the neuronal side of the synaptic cleft. A tool for investigating the paradox of sympathetic nervous system and heart failure in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic Agents; Animals; Cardiomyopathy, Dilated; Catecholamines; Ephedrine; Heart Failure; Humans; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic; Sympathetic Nervous System; Synaptic Transmission | 2001 |
Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.
Topics: 3-Iodobenzylguanidine; Animals; Ephedrine; Heart; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Myocardium; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Tissue Distribution | 2006 |
Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Autonomic Nervous System Diseases; Carbon Radioisotopes; Child; Child, Preschool; Ephedrine; Feasibility Studies; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Ephedrine; Female; Heart; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Discrepant uptake of the radiolabeled norepinephrine analogues hydroxyephedrine (HED) and metaiodobenzylguanidine (MIBG) in rat hearts.
Topics: 3-Iodobenzylguanidine; Animals; Autoradiography; Biological Transport; Coronary Occlusion; Ephedrine; Isotope Labeling; Male; Myocardial Reperfusion; Myocardium; Norepinephrine; Rats; Rats, Wistar | 2013 |
Prone-position acquisition of myocardial (123)I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT.
Topics: 3-Iodobenzylguanidine; Adult; Body Weight; Carbon Isotopes; Catecholamines; Ephedrine; Healthy Volunteers; Heart; Hemodynamics; Humans; Iodine Radioisotopes; Liver; Male; Myocardium; Positron-Emission Tomography; Prone Position; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Chemistry and biology of radiotracers that target changes in sympathetic and parasympathetic nervous systems in heart disease.
Topics: 3-Iodobenzylguanidine; Ephedrine; Heart; Heart Diseases; Heart Failure; Humans; Ligands; Norepinephrine; Parasympathetic Nervous System; Protein Binding; Radionuclide Imaging; Sympathetic Nervous System | 2015 |
Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System Diseases; Ephedrine; Fluorine Radioisotopes; Fluorobenzenes; Guanidines; Isotope Labeling; Kinetics; Metabolic Clearance Rate; Organ Specificity; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |